Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cristini, V.
Right arrow Articles by Sinek, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cristini, V.
Right arrow Articles by Sinek, J.
Clinical Cancer Research Vol. 11, 6772-6779, October 1, 2005
© 2005 American Association for Cancer Research


Human Cancer Biology

Morphologic Instability and Cancer Invasion

Vittorio Cristini1,2, Hermann B. Frieboes1, Robert Gatenby3,4, Sergio Caserta5, Mauro Ferrari6,7 and John Sinek2

Authors' Affiliations: Departments of 1 Biomedical Engineering and 2 Mathematics, University of California, Irvine, California; Departments of 3 Radiology and 4 Applied Mathematics, University of Arizona, Tucson, Arizona; 5 Department of Chemical Engineering, University of Naples "Federico II," Naples, Italy; 6 Davis Heart and Lung Research Institute, Ohio State University, Columbus, Ohio; and 7 National Cancer Institute, Bethesda, Maryland

Requests for reprints: Vittorio Cristini, Department of Biomedical Engineering, REC 204, University of California, Irvine, CA 92697-2715. Phone: 949-824-9132; Fax: 949-824-1727; E-mail: cristini{at}math.uci.edu.

Purpose: A solid tumor embedded in host tissue is a three-dimensional arrangement of cells and extracellular matrix that acts as a sink of oxygen and cell nutrients, thus establishing diffusional gradients. This and variations in vascular density and blood flow typically produce intratumoral regions of hypoxia and acidosis, and may result in spatially heterogeneous cell proliferation and migration. Here, we formulate the hypothesis that through these mechanisms, microenvironmental substrate gradients may drive morphologic instability with separation of cell clusters from the tumor edge and infiltration into surrounding normal tissue.

Experimental Design: We used computer simulations and in vitro experiments.

Results: We provide evidence that morphologic instability could be suppressed in vivo by spatially homogeneous oxygen and nutrient supply because normoxic conditions act both by decreasing gradients and increasing cell adhesion and, therefore, the mechanical forces that maintain a well-defined tumor boundary. A properly working tumor microvasculature can help maintain compact noninfiltrating tumor morphologies by minimizing oxygen and nutrient gradients. In contrast, antiangiogenic therapy, by increasing microenvironmental heterogeneity, may promote morphologic instability, leading to invasive patterns even under conditions in which the overall tumor mass shrinks.

Conclusions: We conclude that therapeutic strategies focused solely on reduction of vascular density may paradoxically increase invasive behavior. This theoretical model accounts for the highly variable outcome of antiangiogenic therapy in multiple clinical trials. We propose that antiangiogenic strategies will be more consistently successful when aimed at "normalizing" the vasculature and when combined with therapies that increase cell adhesion so that morphologic instability is suppressed and compact, noninvasive tumor morphologies are enforced.




This article has been cited by other articles:


Home page
Biophys. JHome page
A. M. Stein, T. Demuth, D. Mobley, M. Berens, and L. M. Sander
A Mathematical Model of Glioblastoma Tumor Spheroid Invasion in a Three-Dimensional In Vitro Experiment
Biophys. J., January 1, 2007; 92(1): 356 - 365.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Z. F. Yang, R. T.P. Poon, Y. Liu, C. K. Lau, D. W. Ho, K. H. Tam, C. T. Lam, and S. T. Fan
High doses of tyrosine kinase inhibitor PTK787 enhance the efficacy of ischemic hypoxia for the treatment of hepatocellular carcinoma: dual effects on cancer cell and angiogenesis.
Mol. Cancer Ther., September 1, 2006; 5(9): 2261 - 2270.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. B. Frieboes, X. Zheng, C.-H. Sun, B. Tromberg, R. Gatenby, and V. Cristini
An Integrated Computational/Experimental Model of Tumor Invasion
Cancer Res., February 1, 2006; 66(3): 1597 - 1604.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.